STAKEHOLDERS MEETING IN ADDIS ABABA

Photo: AHRI

Original text published on the University of Bergen (UiB) website

A crucial discussion recently took place among stakeholders regarding a new rapid testing and treatment strategy aimed at combating Cryptosporidiosis Diarrhea (CryptoT&T) in children. The initiative seeks to curb the spread of the disease and mitigate its harmful effects on child lives.

Cryptosporidiosis is an intestinal infection caused triggered by the Cryptosporidium parasite. It predominantly affects children, leading to severe diarrhea that can persist for days or even weeks. Transmission typically occurs through contaminated water or food, with poor hygiene significantly accelerating its spread. This infection poses a particularly serious threat to vulnerable children and those with compromised immune systems.

The core of this new strategy centers on integrating rapid diagnostic methods with immediate treatment. This innovative approach enables healthcare professionals at clinics and health facilities to make swift treatment decisions without the delay of waiting for laboratory results. This is especially vital in remote areas or regions lacking access to conventional laboratory services, as a quick diagnosis is paramount for prompt and effective treatment.

The primary objectives of this study include reducing the severity and duration of the disease, controlling its spread, decreasing child mortality rates, and enhancing overall health service delivery.